| Ytd | 9.45% | |
| 1y | 29.30% |
| Open | 26.30 | Prev Close | 26.31 | Low | 26.01 | High | 27.13 | Mkt Cap | 3.32B |
| Vol | 23.51K | Avg Vol | 1.13M | EPS | 0.16 | P/E | 164.44 | Forward P/E | 29.50 |
| Beta | 0.83 | Short Ratio | 3.29 | Inst. Own | 97.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 24.16 | 200-d Avg | 23.63 | 1yr Est | 31.74 |
PRVA News
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and l
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Out
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and rais
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points.